Antibiotic therapy in sepsis: No next time for a second chance!
- PMID: 33710622
- DOI: 10.1111/jcpt.13403
Antibiotic therapy in sepsis: No next time for a second chance!
Abstract
What is known and objective: Sepsis is a life-threatening organ dysfunction associated with a high rate of morbidity and mortality. Appropriate antibiotic therapy remains the cornerstone of sepsis and septic shock management.
Comment: Although the early initiation of antimicrobial agents in the treatment of sepsis is widely acknowledged, the selection and adjustment to optimal dosage can be equally important. Since significant pathophysiological changes in the critically ill patients lead to altered pharmacokinetics of antibiotics, early consideration of pharmacokinetic/pharmacodynamic (PK/PD) properties is necessary for optimal antibiotic dosing in sepsis and should be integrated in practice.
What is new and conclusion: Where possible, an individualized antibiotic dosing approach through the application of therapeutic drug monitoring (TDM) service should replace the conventional dosing in critically ill patients with sepsis. Finally, antimicrobial stewardship can help improve clinical outcomes.
Keywords: Acute Kidney Injury (AKI); Antibiotic Dosing; Antimicrobial Agents; Augmented Renal Clearance (ARC); Critical Illness; Dose Adjustment; Pharmacodynamics; Pharmacokinetics; Sepsis; Therapeutic Drug Monitoring (TDM).
© 2021 John Wiley & Sons Ltd.
Similar articles
-
Key Challenges in Providing Effective Antibiotic Therapy for Critically Ill Patients with Bacterial Sepsis and Septic Shock.Clin Pharmacol Ther. 2021 Apr;109(4):892-904. doi: 10.1002/cpt.2203. Epub 2021 Mar 6. Clin Pharmacol Ther. 2021. PMID: 33570163 Review.
-
The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?Diagn Microbiol Infect Dis. 2014 May;79(1):77-84. doi: 10.1016/j.diagmicrobio.2014.01.015. Epub 2014 Jan 24. Diagn Microbiol Infect Dis. 2014. PMID: 24602849
-
Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.Trials. 2019 Jun 6;20(1):330. doi: 10.1186/s13063-019-3437-x. Trials. 2019. PMID: 31171029 Free PMC article.
-
[Adequate anti-infective treatment : Importance of individual dosing and application].Anaesthesist. 2018 Jun;67(6):461-476. doi: 10.1007/s00101-018-0443-4. Anaesthesist. 2018. PMID: 29766208 Review. German.
-
Therapeutic drug monitoring of β-lactam antibiotics in the ICU.Expert Rev Anti Infect Ther. 2020 Nov;18(11):1155-1164. doi: 10.1080/14787210.2020.1788387. Epub 2020 Jul 5. Expert Rev Anti Infect Ther. 2020. PMID: 32597263 Review.
Cited by
-
Recent Advances in Monoclonal Antibody-Based Approaches in the Management of Bacterial Sepsis.Biomedicines. 2023 Mar 2;11(3):765. doi: 10.3390/biomedicines11030765. Biomedicines. 2023. PMID: 36979744 Free PMC article. Review.
-
Pharmacokinetic study of high-dose oral rifampicin in critically Ill patients with multidrug-resistant Acinetobacter baumannii infection.Daru. 2022 Dec;30(2):311-322. doi: 10.1007/s40199-022-00449-5. Epub 2022 Sep 7. Daru. 2022. PMID: 36069988 Free PMC article.
-
Pulsed Electromagnetic Field (PEMF) Treatment Reduces Lipopolysaccharide-Induced Septic Shock in Mice.Int J Mol Sci. 2022 May 18;23(10):5661. doi: 10.3390/ijms23105661. Int J Mol Sci. 2022. PMID: 35628471 Free PMC article.
-
Relationship between amikacin pharmacokinetics and biological parameters associated with organ dysfunction: a case series study of critically ill patients with intra-abdominal sepsis.Eur J Hosp Pharm. 2022 Mar;29(e1):e72-e76. doi: 10.1136/ejhpharm-2021-003089. Epub 2021 Nov 11. Eur J Hosp Pharm. 2022. PMID: 34764144 Free PMC article.
-
Management of a critically ill patient with COVID-19-related fulminant myocarditis: A case report.Respir Med Case Rep. 2022;36:101611. doi: 10.1016/j.rmcr.2022.101611. Epub 2022 Feb 18. Respir Med Case Rep. 2022. PMID: 35223423 Free PMC article.
References
REFERENCES
-
- Kim HI, Park S. Sepsis: Early recognition and optimized treatment. Tuberc Resp Dis. 2019;82(1):6-14.
-
- Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Intensive Care Med. 2018;44(6):925-928.
-
- Schmidt G, Mandel J. Evaluation and management of suspected sepsis and septic shock in adults. UpToDate. Updated April 17, 2020.
-
- Andersson M, Östholm-Balkhed Å, Fredrikson M, et al. Delay of appropriate antibiotic treatment is associated with high mortality in patients with community-onset sepsis in a Swedish setting. Eur J Clin Microbiol Infect Dis. 2019;38(7):1223-1234.
-
- Noroozi B, Hadi AM, Shahrami B, et al. Sepsis-associated cholestasis: the impact of mitochondrial dysfunction (A Case Report). Iraqi National Journal of Medicine. 2020;3(1):44-48.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical